{"id":"doi:10.1093/eurheartj/ehv028","kind":"article","title":"Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial","authors":["Christopher Paul Cannon","Bertrand Cariou","Dirk Jacobus Blom","James M. McKenney","Christelle Lorenzato","Robert C. Pordy","Umesh Chaudhari","Helen Martina Colhoun"],"author_count":8,"year":2015,"published":"2015-02-16","venue":"European Heart Journal","cited_by":400,"doi":"10.1093/eurheartj/ehv028","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1093/eurheartj/ehv028","archive_url":"https://space-kitty.com/papers/doi:10.1093/eurheartj/ehv028","updated":null,"pmid":"25687353","pmcid":null,"openalex_id":"W2141898196","pdf_url":"https://academic.oup.com/eurheartj/article-pdf/36/19/1186/17355154/ehv028.pdf","abstract":null,"abstract_license":null,"license":"cc-by-nc","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}